Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
11/09/1995 | CA2189543A1 Thymidine kinase mutants |
11/09/1995 | CA2189052A1 Compositions and method of stimulating the proliferation and differentiation of human fetal and adult pancreatic cells ex vivo |
11/09/1995 | CA2189032A1 Enhancing the sensitivity of tumor cells to therapies |
11/09/1995 | CA2188648A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
11/08/1995 | EP0680745A2 Use of antifungals and or halogenated antibacterial agents for diminishing hair loss |
11/08/1995 | EP0680346A1 Method of increasing the concentration of nitric oxide in blood |
11/08/1995 | EP0680331A1 Recombinant virus immunotherapy |
11/08/1995 | EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
11/08/1995 | EP0680316A1 Novel parasitic helminth proteins |
11/08/1995 | EP0680315A1 Method for preparing a viral aerosol |
11/08/1995 | CN1111148A Acupoint application for myopia |
11/08/1995 | CN1030229C Method of preparing the whole scorpion wine |
11/08/1995 | CN1030222C Infused preparation of replenishing 'qi' and blood and making method thereof |
11/08/1995 | CN1030221C Blood-enriching infused preparation and its making method |
11/07/1995 | US5464835 Antiinflammatory agents |
11/07/1995 | CA1337519C Antibiotic ge 2270 |
11/07/1995 | CA1337518C Monoclonal antibodies against tnf-, hybridomas producing them and method for the purification of tnf- |
11/02/1995 | WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof |
11/02/1995 | WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis |
11/02/1995 | WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft |
11/02/1995 | WO1995028948A1 Compositions comprising dna damaging agents and p53 |
11/02/1995 | EP0679405A1 Method for separating viruses from protein solutions |
11/02/1995 | EP0679402A2 Biologically active substance-secreting hybrid gel |
11/02/1995 | EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene |
11/02/1995 | EP0679182A1 Delivery of gene products via mesangial cells |
11/02/1995 | EP0679101A1 Apparatus for delivering drugs into red blood corpuscles. |
11/02/1995 | EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
11/02/1995 | EP0491956B1 Reveromycin a, production thereof, and antitumor drug and fungicide |
11/02/1995 | CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft |
11/02/1995 | CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof |
11/01/1995 | CN1111058A Inhibitor of collagen-stimulated platelet aggregation |
11/01/1995 | CN1110922A Navel medicine bag for treatment of indigestion and child digestive disorder and its prepn. |
11/01/1995 | CN1110921A Navel medicine bag for treatment of hypertension and cerebral arteriosclerosis and its prepn. |
11/01/1995 | CN1110920A Medicament for treatment of hyerosteogeny and its prepn. |
11/01/1995 | CN1110916A health-care oral liquor containing pinenut oil, bee honey and others |
11/01/1995 | CN1110915A Method for prepn. of cerebral proteolytic liquid-cerebral health injection |
11/01/1995 | CN1030166C Method for prodn. of external-use medicinal bag for prevention and treatment of cancer |
10/31/1995 | US5462752 Inhibition of platelet binding |
10/31/1995 | US5462733 Immune system modulation using psoralens activated with visible light |
10/31/1995 | US5462716 Container for receiving and separating a fluid, preferably blood plasma, into its ingredients |
10/26/1995 | WO1995028642A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
10/26/1995 | WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system |
10/26/1995 | WO1995028480A1 Methods of use of uncoated gel particles |
10/26/1995 | WO1995028479A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process |
10/26/1995 | WO1995028412A1 α(1,3) GALACTOSYLTRANSFERASE NEGATIVE SWINE |
10/26/1995 | WO1995028227A1 Aqueous solvent encapsulation method, apparatus and microcapsules |
10/26/1995 | WO1995028172A1 Human bone stimulating factor |
10/26/1995 | WO1995028167A1 Methods of treating disease using sertoli cells and allografts or xenografts |
10/26/1995 | WO1995028166A2 Method for implanting encapsulated cells in a host |
10/26/1995 | WO1995028163A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds |
10/26/1995 | WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes |
10/26/1995 | DE4412612A1 Medical and veterinary use of synthetic humate prods. |
10/26/1995 | CA2188172A1 Human bone stimulating factor |
10/26/1995 | CA2187802A1 .alpha.(1,3) galactosyltransferase negative swine |
10/26/1995 | CA2187779A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
10/26/1995 | CA2187770A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process |
10/26/1995 | CA2187768A1 Aqueous solvent encapsulation method, apparatus and microcapsules |
10/26/1995 | CA2187526A1 Methods of use of uncoated gel particles |
10/26/1995 | CA2187335A1 Method for implanting encapsulated cells in a host |
10/26/1995 | CA2186738A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds |
10/26/1995 | CA2147810A1 Biologically active substance-secreting hybrid gel |
10/26/1995 | CA2147797A1 Method for the removal of viruses from protein solutions |
10/25/1995 | EP0678101A1 Growth differentiation factor-9 |
10/25/1995 | CN1110603A Preparation method of traditional Chinese medicine sheet for bone joint |
10/25/1995 | CN1110598A Hot application for stopping cancer pain |
10/25/1995 | CN1110586A Medicine for treating gonorrhea |
10/25/1995 | CN1110584A Traditional Chinese medicine for dephlogisticate |
10/25/1995 | CN1110580A Anti-virus and antipyretic oral liquid |
10/25/1995 | CN1110578A "Huangpeijing" and its processing method |
10/25/1995 | CN1110575A Medical liquid and its preparation method |
10/25/1995 | CN1110574A "Yangqi" health-care nourishing wine and its preparation method |
10/25/1995 | CN1110563A Injection containing ginseng and astragalus root components |
10/25/1995 | CN1110559A Dongbei forest-frog capsule and its preparation method |
10/25/1995 | CN1110558A Preparation method of antiserum positive injection |
10/25/1995 | CN1110551A Cosmetics and its prepration method and purpose |
10/24/1995 | US5461058 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
10/24/1995 | US5461037 Preventing hyperlipidemia by intravenously infusing a mixture of low dosage phosphates and glyceride oil |
10/24/1995 | US5460939 Temporary living skin replacement |
10/24/1995 | CA2017265C Cosmetic composition against ageing of the skin |
10/19/1995 | WO1995027903A1 A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample |
10/19/1995 | WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
10/19/1995 | WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs |
10/19/1995 | WO1995027398A1 Agent having a protective action against attack by insects or parasites as well as an anti-inflammatory action |
10/19/1995 | WO1995017904A3 Botulinum toxins for treating various disorders and associated pain |
10/19/1995 | DE4413839C1 Prepn. to protect human bodies from oxidative processes |
10/19/1995 | DE4412613A1 Medical and veterinary use of synthetic humate prods. |
10/19/1995 | CA2190961A1 Agent having a protective action against attack by insects or parasites as well as an anti-inflammatory action |
10/19/1995 | CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs |
10/19/1995 | CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
10/18/1995 | EP0677586A1 Recombinant collagenase type II from clostridium histolyticum and its use for the isolation of cells and cellular agglomerations |
10/18/1995 | EP0677110A1 Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same |
10/18/1995 | EP0677107A1 Clotting inhibitor made from protostomia saliva. |
10/18/1995 | EP0677100A1 Method for production of neuroblasts |
10/18/1995 | EP0677044A1 $i(IN VIVO) METHOD OF OBTAINING CELL COMPONENTS |
10/18/1995 | EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
10/18/1995 | EP0495116B1 Anti-human immunodeficiency virus agent |
10/18/1995 | CN1110279A Method for extracting albumen from animal's blood by precipitating method |
10/18/1995 | CN1110175A Oral natural drug composition for curing hysteromyoma |
10/18/1995 | CN1110161A Traditional Chinese Medicine preparation for mainly curing myopia |
10/18/1995 | CN1110160A Nutrient health-care oral liquor containing bee larva nutritive composition |